Thiols — Sulfur-Based Click Handles
The thiol group (–SH) is one of the most versatile and widely used handles in bioconjugation chemistry. Naturally present on cysteine residues in proteins, thiols participate in a rich variety of click-compatible reactions including thiol-ene, thiol-maleimide (Michael addition), disulfide exchange, and thiol-yne chemistry. The unique nucleophilicity and redox activity of thiols make them indispensable for site-selective protein modification, hydrogel cross-linking, and the construction of antibody-drug conjugates.
Chemical Properties
The thiolate anion (RS−) is an exceptionally potent nucleophile, approximately 105 times more reactive than the corresponding thiol (RSH). This pH-dependent reactivity enables selective reactions at mildly alkaline conditions (pH 7.5–8.5) where the thiolate concentration is sufficient for reaction, yet most other biological nucleophiles (amines, hydroxyls) remain unreactive.
Thiol Click Reactions
Thiol-Ene (UV-Mediated)
UV light (365 nm), photoinitiator (e.g., DMPA), RT, minutes
Thiol-Maleimide (Michael Addition)
pH 6.5–7.5, aqueous buffer, RT, 30 min–2 h
Disulfide Exchange
pH 7–8, aqueous buffer, RT, reversible reaction
Thiol-Yne
UV light, photoinitiator, or radical initiator
| Reaction | Partner | Product | Conditions | Reversibility |
|---|---|---|---|---|
| Thiol-Ene | Terminal alkene | Thioether | UV, photoinitiator | Irreversible |
| Thiol-Maleimide | Maleimide | Succinimide thioether | pH 6.5–7.5 | Largely irreversible (retro-Michael possible) |
| Disulfide Exchange | Disulfide | New disulfide | pH 7–8 | Reversible |
| Thiol-Yne | Terminal alkyne | Bis-thioether | UV, radical initiator | Irreversible |
Representative Compounds
| Compound | Description | Primary Use |
|---|---|---|
| Cysteine | Natural amino acid with thiol side chain; MW 121.16 Da | Natural thiol handle on proteins for site-selective modification |
| Thiol-PEG-NHS | Heterobifunctional PEG with thiol and NHS ester termini | Protein PEGylation; thiol attachment to cysteine, NHS to amine |
| 2-Iminothiolane (Traut's reagent) | Thiolating reagent that converts primary amines to thiols; MW 137.63 Da | Introduction of thiol handles onto amine-bearing molecules (antibodies, proteins) |
| SPDP | N-succinimidyl 3-(2-pyridyldithio)propionate; heterobifunctional crosslinker | Cleavable disulfide crosslinker for reversible conjugation |
| Sulfo-SMCC | Sulfosuccinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate | Non-cleavable amine-to-thiol crosslinker; used in ADC production |
| Maleimide-fluorophores | Fluorophores (Alexa, Cy, TAMRA, BODIPY) with maleimide handle | Fluorescent labeling of cysteine residues on proteins |
Site-Selective Protein Modification
Cysteine Engineering
Strategic introduction or removal of cysteine residues by site-directed mutagenesis to create proteins with single, accessible thiol handles for site-specific conjugation. This is the basis of THIOMAB technology (Genentech)[11].
Disulfide Rebridging
Reduction of native inter-chain disulfides in antibodies followed by rebridging with bis-electrophilic linkers (e.g., dibromopyridazinediones). This produces homogeneous conjugates with defined stoichiometry without engineering new cysteines.
Thiol-Maleimide Conjugation
The classical approach: reduction of disulfides to generate free thiols, followed by reaction with maleimide-functionalized payloads. Used in most clinically approved ADCs. Limitations include conjugate heterogeneity and potential retro-Michael reaction in vivo.
Applications
Antibody-Drug Conjugates (ADCs)
Thiol-maleimide conjugation is the most widely used chemistry in clinically approved ADCs, including Adcetris (brentuximab vedotin) and Kadcyla (trastuzumab emtansine). Inter-chain disulfide reduction generates thiols for payload attachment.
FDA-ApprovedHydrogel Cross-Linking
Thiol-ene and thiol-Michael addition reactions are widely used for hydrogel formation and cross-linking. Multi-arm PEG-thiol and PEG-acrylate or PEG-maleimide precursors form hydrogels under mild conditions suitable for cell encapsulation.
BiomaterialsProtein PEGylation
Thiol-reactive PEG reagents (maleimide-PEG, vinyl sulfone-PEG) are conjugated to surface cysteines to increase protein half-life, reduce immunogenicity, and improve pharmacokinetics of therapeutic proteins.
TherapeuticsSurface Functionalization
Thiol-gold chemistry (self-assembled monolayers, SAMs) and thiol-ene reactions are used to functionalize gold surfaces, nanoparticles, and microarrays with biomolecules for biosensing, diagnostics, and tissue engineering.
SurfacesThiol-maleimide conjugation is used in FDA-approved antibody-drug conjugates such as Adcetris (brentuximab vedotin, approved 2011 for Hodgkin lymphoma)[11]. The maleimide-thiol linkage provides a stable thiosuccinimide bond. However, in vivo retro-Michael reaction can lead to payload exchange with serum albumin — newer linker designs (e.g., hydrolyzed maleimides, bromomaleimides) address this limitation.
Free thiols are readily oxidized to disulfides upon exposure to air. Always handle thiol-containing compounds under inert atmosphere or in the presence of a reducing agent (TCEP, DTT). For protein labeling, reduce disulfides with TCEP immediately before the conjugation reaction and remove excess reducing agent by desalting if it will interfere with the downstream reaction.